New Jersey gets high on its own supply as legal weed sales begin
Send a link to a friend
[April 22, 2022]
By Joseph Ax
LAWRENCE, N.J. (Reuters) -Last year, Xavier
Rodriguez got two convictions for marijuana possession expunged from his
record, thanks to a new law legalizing the drug in New Jersey.
On Thursday, the 28-year-old was among the initial wave of New Jerseyans
waiting in long lines to buy marijuana lawfully, as 13 dispensaries
around the state began selling to all residents 21 and older for the
first time.
"No more being hassled and having to hide out," said Rodriguez, standing
outside the Zen Leaf dispensary in Lawrence, New Jersey, with his
60-year-old mother, Debra, who uses marijuana for pain caused by
rheumatoid arthritis.
Thursday's debut marked the culmination of a decade-long effort by
advocates in the state to legalize recreational use and end years of
racially unbalanced criminal prosecution. New Jersey is one of 18 states
and the District of Columbia to have legalized adult marijuana use.
"We see it as the end of Prohibition 2.0," said Ben Kovler, chief
executive of Green Thumb Industries, which operates dispensaries in
Paterson and Bloomfield.
The 13 locations are owned by Ascend Wellness Holdings Inc, Columbia
Care Inc, Acreage Holdings Inc, Green Thumb Industries Inc, Curaleaf
Holdings Inc, Terrascend Corp and Verano Holdings Corp.
Industry executives and analysts expect the market will eventually
exceed $2 billion. Governor Phil Murphy's proposed budget anticipates
$121 million in cannabis revenue, mostly from taxes and fees, in fiscal
year 2023.
There are currently 130,000 medical marijuana patients in New Jersey,
and the state's Cannabis Regulatory Commission estimates there are
roughly 800,000 potential recreational customers.
"The goal here is to take people away from the black market and bring
them into the safe, legal market," said George Archos, chief executive
of Verano, which owns the Zen Leaf in Lawrence.
More than 100 people stood in a line snaking around Zen Leaf's building
on Thursday morning. Employees with tablets offered advice on choosing
from a menu of products ranging from Ethos Cookies ("frosty and
delicious") to Chemlatto 33 ("earthy and rich") - both hybrid strains of
smokable cannabis.
[to top of second column]
|
A man arrives to buy recreational marijuana at the Apothecarium
marijuana dispensary on the first day recreational sales are allowed
for customers over the age of 21, in Maplewood, New Jersey, U.S.,
April 21, 2022. REUTERS/Eduardo Munoz
Dean Miller, 39, said he has a
medical card for marijuana but chose to wait in the adult-use line
to show support for what he called "a big day for New Jersey."
He said he hoped legalization would help educate people on
marijuana's therapeutic effects, without the downsides of substances
such as alcohol.
"I'm not just looking to get high," said Miller, who relies on daily
marijuana to cope with pain from six surgeries.
'PURSUING EQUITY'
Only medical marijuana dispensaries can sell to adults for now, but
the commission is weighing hundreds of applications from start-up
businesses. Those owned by people with marijuana convictions, as
well as minorities, women and disabled veterans, receive priority
consideration under the law.
The law requires much of the state's cannabis revenue to be invested
in communities most harmed by the "war on drugs."
In 2018, Black people were arrested more than three times as often
as white people for marijuana offenses despite similar usage rates,
according to the American Civil Liberties Union of New Jersey.
"That's the whole point here: making sure we're pursuing equity
every step of the way and ending our reliance on a criminal response
for something that people consume all over the country," said Amol
Sinha, the group's executive director.
Cannabis executives hope a successful launch in New Jersey will spur
other East Coast states to take action, noting that polls show a
majority of Americans support legalizing marijuana.
"It's time for legislators to catch up with the American consumer,"
said Joe Bayern, the chief executive of Curaleaf.
(Reporting by Joseph AxEditing by Bill Berkrot)
[© 2022 Thomson Reuters. All rights
reserved.] This
material may not be published, broadcast, rewritten or
redistributed.
Thompson Reuters is solely responsible for this content. |